Baupost Group LLC MA Buys New Stake in Molina Healthcare, Inc $MOH

Baupost Group LLC MA bought a new stake in Molina Healthcare, Inc (NYSE:MOH) in the 4th quarter, Holdings Channel.com reports. The fund bought 625,000 shares of the company’s stock, valued at approximately $108,463,000. Molina Healthcare accounts for about 2.1% of Baupost Group LLC MA’s investment portfolio, making the stock its 17th largest position.

Several other institutional investors have also recently added to or reduced their stakes in MOH. CenterBook Partners LP grew its stake in shares of Molina Healthcare by 359.7% in the third quarter. CenterBook Partners LP now owns 20,409 shares of the company’s stock worth $3,905,000 after acquiring an additional 15,969 shares in the last quarter. BNP Paribas Financial Markets grew its stake in shares of Molina Healthcare by 63.0% in the fourth quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock worth $76,248,000 after acquiring an additional 169,739 shares in the last quarter. Fiera Capital Corp grew its stake in shares of Molina Healthcare by 68.8% in the third quarter. Fiera Capital Corp now owns 241,581 shares of the company’s stock worth $46,229,000 after acquiring an additional 98,431 shares in the last quarter. DDD Partners LLC acquired a new position in shares of Molina Healthcare in the third quarter worth $1,743,000. Finally, Timber Creek Capital Management LLC acquired a new position in shares of Molina Healthcare in the third quarter worth $4,467,000. Institutional investors and hedge funds own 98.50% of the company’s stock.

Analyst Ratings Changes

MOH has been the subject of several research reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $129.00 price target on shares of Molina Healthcare in a research note on Friday, April 24th. JPMorgan Chase & Co. boosted their price target on shares of Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a research note on Monday, June 8th. Truist Financial boosted their price target on shares of Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. Sanford C. Bernstein restated an “outperform” rating on shares of Molina Healthcare in a research note on Friday, March 13th. Finally, Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, May 2nd. Three analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $182.73.

Insider Buying and Selling at Molina Healthcare

In other news, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is currently owned by insiders.

Molina Healthcare Price Performance

Molina Healthcare stock opened at $200.55 on Friday. The stock has a market cap of $10.45 billion, a P/E ratio of 59.33 and a beta of 0.80. The company has a fifty day simple moving average of $174.79 and a 200-day simple moving average of $164.50. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $311.52. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The company’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same period in the previous year, the company earned $6.08 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities analysts expect that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.